BODYWELLE’s Dr. Alonso Martin Explains the Benefits of Botox for Facial Rejuvenation
The Miami Beach physician describes how neuromodulators soften expression lines, where treatment can be applied, and why dosing and placement...
Diagnostics
Vespexx Recognized as Finalist for the Digital Health Hub Foundation Digital Health & AI Awards 2026 at HLTH
SEOUL, South Korea, Oct. 22, 2026 /PRNewswire/ -- Vespexx Inc., an AI-driven femtech company, today announced it has been named...
Vespexx Recognized as Finalist for the Digital Health Hub Foundation Digital Health & AI Awards 2026 at HLTH
SEOUL, South Korea, Oct. 22, 2026 /PRNewswire/ -- Vespexx Inc., an AI-driven femtech company, today announced it has been named...
DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies
Proprietary IP Position Until At Least 2042 to Enable Consolidation of Infrastructure targeting market expected to grow from $9.6 billion...
[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum in the third quarter with sales growth of +7% at constant exchange rates (CER) and +8% in CHF; Group sales increase +6% (CER), +1% in CHF, in the first nine […]
Ad hoc announcement pursuant to Art. 53 LRBasel, 22 October 2026 Roche continues strong momentum in the third quarter with...
Teknova to Report Third Quarter 2026 Financial Results on November 4, 2026
HOLLISTER, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents...
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON NOVEMBER 4, 2026
SALT LAKE CITY, Oct. 21, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal...
Fountain Life Named Longevity Clinic of the Year for Second Consecutive Year
Recognized by peers at the Roundtable of Longevity Clinics, the 2026 award honors Fountain Life's leadership in data-driven longevity medicine,...
Custom Health to Close the Market at the TSX on October 22, 2026, and Announces Appointments of Chief Commercial and Strategy Officer and Chief Compliance and Regulatory Officer
Custom Health will close the market at the Toronto Stock Exchange on October 22, 2026, to celebrate the Company's recent...
Kylo Peptides Marks Record Month as Brand Searches Nearly Triple
Sheridan, Wyoming, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides , a research peptide supplier, recorded its highest month of...
Teknova Announces Pricing of $40 Million Public Offering of Common Stock
HOLLISTER, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents...
Telix Reports Third Quarter 2026 Financial Performance
MELBOURNE, Australia and INDIANAPOLIS, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) provides a...
Metabolon Announces New Bioinformatics Application to Translate Metabolomic Biomarkers into Actionable Multiomic Hypotheses
New bioinformatics application combines curated metabolite-protein knowledge, advanced network algorithms, interactive exploration, and optional AI interpretation to generate clearer mechanistic...
Sensydia Appoints Brit Gould as Chief Commercial Officer to Lead Commercialization of the Cardiac Performance System (CPS™)
Commercial leader who has guided Sensydia's path to market takes on full commercial responsibility as the company builds its team...
EY Pulse of the MedTech Industry Report 2026: Blockbuster performers and innovation drive record MedTech industry growth
Broader MedTech industry at turning point, seeking positioning to optimize portfolios, differentiate technology and improve R&DInnovation drives increased dealmaking and...
EVIDENT Expands Its Pramana Digital Pathology Portfolio to Support Small and Medium-Sized Labs
The new Pramana™ POD benchtop WSI scanner delivers autonomous imaging to help laboratories create pathologist-ready whole slide images with minimal...
Science and Medicine Group (SMG) Names Jasen Holness Senior Vice President, Sales and Marketing to Accelerate Customer Growth
Veteran market research and commercial leader will oversee sales and marketing across all of SMG's insights and digital media brands...
FDA approves Roche’s Enspryng, a first-in-class IL-6R inhibitor, as the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)
FDA approval based on Phase III SatraGO-1 and -2 studies, with SatraGO-2 demonstrating a significant reduction in eye bulging (proptosis)...
Pillar Biosciences and Collaborators to Present NGS Data Across Solid Tumors, Liquid Biopsy, and Heme Malignancies at 2026 Association for Molecular Pathology (AMP) Annual Meeting
NATICK, Mass., Oct. 15, 2026 /PRNewswire/ -- Pillar Biosciences today announced that ten scientific posters featuring their NGS technology will...
Valion Bio’s Next-Generation NMR Partnership with LarmorBio Delivers Initial Feasibility Milestone
Velocity Bioworks successfully completes initial evaluation of LarmorBio's BioScan-NMR™ platform, generating data supporting the continued development of continuous, real-time, non-invasive...